Tuberculosis in a solid-organ transplant recipient: modern-day implications.
The clinical presentation and disease course of tuberculosis (TB) in a solid-organ transplant (SOT) recipient may be atypical and the risk of mortality is high. Herein we examine the role of the different tests used in diagnosis of TB and review the specifics of anti-mycobacterial therapy and the public health implications of TB in a SOT recipient.
Jazrawi
Ayad
A
UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA.
Jones
Makoto
M
Kfoury
Abdallah G
AG
Fisher
Patrick W
PW
Gilbert
Edward M
EM
Bader
Feras
F
Pombo
David
D
Hanson
Kim E
KE
Stehlik
Josef
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000601:surgery; D004359:Drug Therapy, Combination; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000382:microbiology*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents